Professional Documents
Culture Documents
Original Article
T
Abstract halassemia is an inherited hemoglobin disorder
Background Thalassemia is a chronic disease that is becoming a that is becoming a major health problem in
major health problem in the world, including the Mediterranean, the world, especially in Mediterranean region,
as well as Malaysia, Thailand and Indonesia. This condition clearly the Middle East, the Indian subcontinent,
DIIHFWVWKHSDWLHQW·VTXDOLW\RIOLIHEHFDXVHRIWKHFRQGLWLRQLWVHOIDQG
the effects of treatment. Assessment is needed to determine actions
6RXWKHDVW$VLD0DOD\VLD7KDLODQGDQG,QGRQHVLD1-3
to be taken to improve the quality of life in thalassemic children. ,W KDV EHHQ HVWLPDWHG WKDW DSSUR[LPDWHO\ RI WKH
Objective To assess the differences in quality of life of thalassemic world population are carriers of such disorders and
children compared to their normal siblings. WKDW ² EDELHV ZLWK VHYHUH IRUPV RI
Methods:HSHUIRUPHGDFURVVVHFWLRQDOVWXG\IURP0D\ WKHVHGLVHDVHVDUHERUQHDFK\HDU:+24 In
XQWLO-XQHLQ+$GDP0DOLN+RVSLWDO0HGDQDQGWKHKRPH
1RUWK6XPDWUDWKHFDUULHUSRSXODWLRQUHDFKHG
RIDPHPEHURIWKH1RUWK6XPDWUD&KDSWHURIWKH$VVRFLDWLRQRI
3DUHQWVRI7KDODVVHPLD6XIIHUHUV3HUKLPSXQDQ2UDQJWXD3HQGHULWD FRQVLVWLQJ RI DOSKD WKDODVVHPLD DQG
7DODVHPLD,QGRQHVLD3237,7KDODVVHPLFFKLOGUHQDJHG beta thalassemia.5 Children with thalassemia appear
years and their age and gender-adjusted siblings were divided into healthy at birth, but develop anemia that becomes
WZRJURXSVFDVHJURXSDQGFRQWUROJURXS3DUHQWVDQGFKLOGUHQ progressively worse due to the partial or total absence
ZHUHDVNHGWRILOOWKH3HGV4/3HGLDWULF4XDOLW\RI/LIH,QYHQWRU\
YHUVLRQTXHVWLRQQDLUHWRDVVHVVWKHLUTXDOLW\RIOLIH
of hemoglobin. Because of this condition, they need
Results 7KHUHZHUHFKLOGUHQLQHDFKJURXS7KHDVVHVVPHQWVRI regular blood transfusions for the rest of their lives to
four quality of life domains in the thalassemic group vs the control manage chronic anemia and hemoglobin levels.1,5,6
JURXSVKRZHGWKHIROORZLQJSK\VLFDOIXQFWLRQYV Regular blood transfusions lead to iron accumulation in
&,WR3 HPRWLRQDOIXQFWLRQYV organs and may disrupt organ function and/or damage
&,WR3 VRFLDOIXQFWLRQYV
&,WR3 DQGVFKRROIXQFWLRQYV
organs. Iron overload causes most of the mortality
&,WR3 7RWDOVFRUHVZHUH and morbidity associated with thalassemia. Long term
YV&,WR3 6FKRROIXQFWLRQZDV transfusions should be accompanied by therapy with
the most affected parameter studied, with thalassemic children iron chelating agents.
scoring lower than the control group.
Conclusion There were significant decreases in the quality of
life parameters in the thalassemic group compared to the control
group. Thalassemic children have poorer quality of life compared
to their normal siblings, with school function being the most
affected domain. [Paediatr Indones. 2011;51:163-9]. )URP WKH 'HSDUWPHQW RI &KLOG +HDOWK 8QLYHUVLW\ RI 1RUWK 6XPDWUD
Medical school /Adam Malik Hospital, Medan, Indonesia.
Thalassemia has a negative impact on quality of In this study, quality of life assessment was
life due to the effects of the disease and its treatment, SHUIRUPHG XVLQJ WKH 3HGLDWULF 4XDOLW\ RI /LIH
QRWRQO\DIIHFWLQJFKLOGUHQV·SK\VLFDOIXQFWLRQEXWDOVR ,QYHQWRU\3HGV4/*HQHULF&RUH6FDOH7KLV
their social, emotional, and school function, leading questionnaire includes parallel child self-reports (age
to an impaired quality of life. The most commonly UDQJHV DQG \HDUV 3HGV4/
affected domains previously reported were feelings of items ask how much of a problem a particular issue
depression, anxiety, psychological problems, emotional has been for patients during a certain period. Item
burden, hopelessness, difficulty with social integration, responses are measured on a five-point rating scale,
and school problems. 6LPLODU FRQGLWLRQV DOVR UDQJLQJ IURP QHYHU D SUREOHP WR DOPRVW
affected their family members, such as sadness, DOZD\V D SUREOHP 7KH LWHPV FRQVLVW RI
disappointment, hopelessness, stress, depression, and items on physical function, 5 items on emotional
DQ[LHW\DERXWWKHLUFKLOGUHQ·VOLYHV13 The assessment function, 5 items on social function, and 5 items on
of quality of life in thalassemic children and their family school function, yielding a total score. Each scale
members is important in order to determine actions to KDVDVFRUHUDQJLQJIURPZLWKKLJKHUVFRUHV
be taken to improve quality of life. The aim of this study indicating higher quality of life.
was to assess differences in quality of life of thalassemic This study was approved by the Medical Ethics
children compared to their normal siblings. &RPPLWWHH RI WKH 8QLYHUVLW\ RI 6XPDWUD 8WDUD
0HGLFDO6FKRRO
:HXVHG6366YHUVLRQDQG0LFURVRIW([FHO
Methods IRUGDWDSURFHVVLQJ,QGHSHQGHQWWWHVWZDVXVHG
to compare differences in quality of life between the
We conducted a cross-sectional study from May - WZRJURXSV'LIIHUHQFHVZHUHFRQVLGHUHGVLJQLILFDQW
-XQHLQ$GDP0DOLN+RVSLWDO0HGDQDQGWKH DW3DQGD&,
KRPHRIRQHRI1RUWK6XPDWUD·V3237,PHPEHUV:H
LQFOXGHGFKLOGUHQDJHG\HDUVRIDOOWKDODVVHPLD
classifications and their normal siblings, with age at Results
RQVHWRIDQHPLD\HDUVDQGDJHDWILUVWWUDQVIXVLRQ
\HDUVDVZHOODVSUHWUDQVIXVLRQKHPRJORELQOHYHO Thalassemic children and their normal siblings were
JG/3DUHQWVDQGFKLOGUHQJDYHLQIRUPHGZULWWHQ recruited to this study. There were 136 children,
consent, and filled questionnaires completely. We ZLWKWKDODVVHPLDDQGQRUPDOVLEOLQJV2XWRI
excluded children with cognitive function problems, FKLOGUHQ FKLOGUHQ ZHUH H[FOXGHG IURP WKLV
psychotic problems and cancer. study because 4 children were below 5 years of age, 5
6XEMHFWV ZHUH GLYLGHG LQWR WZR JURXSV WKH FKLOGUHQZHUHPRUHWKDQ\HDUVRIDJHFKLOGUHQ
thalassemic group and their normal siblings group. We had mental retardation, and 7 children had no
measured anthropometric values of each child before VLEOLQJV7KHFKLOGUHQZKRIXOILOOHGWKHLQFOXVLRQ
the study began. Weight was measured with Camry® FULWHULDZHUHGHYLGHGLQWRWZRJURXSVWKDODVVHPLF
VFDOHVDQGKHLJKWZDVPHDVXUHGZLWKD0LFURWRLVH0 FKLOGUHQ RU FDVH JURXS DQG QRUPDO VLEOLQJV RU
stature meter. control group.
3DUHQWV DQG FKLOGUHQ ZHUH DVNHG WR ILOO WKH 7KHDYHUDJHDJHLQERWKJURXSVZDV\HDUV
3HGV4/ YHUVLRQ TXHVWLRQQDLUHV DIWHU UHFHLYLQJ PRVWFRPPRQO\ER\V7KHQXWULWLRQVWDWXVRI
directions and explanations on the meaning of each both groups was normal and the most common level of
question. We collected and reviewed questionnaire HGXFDWLRQZDVSULPDU\VFKRRO0RVWFRPPRQSDUHQWV·
sheets after they were completely filled. The education level was high school with self-owned
completed questionnaires were adjusted for age and business as their main profession. (Table 1)
JHQGHU'DWDIRUHDFKGRPDLQSK\VLFDOHPRWLRQDO Table 2 shows the hematologic profile of the
social, and school functions) were tabulated. Children thalassemic children. This profile was consistent
with significantly poor quality of life were referred to with the thalassemia condition. We found the most
a child psychologist. FRPPRQ DJH DW RQVHW RI DQHPLD ZDV \HDUV
Table 3. Differences in quality of life between thalassemic children and their normal siblings
Case group Control group
Quality of life (n=59) (n=59) 95% CI P
mean (SD) mean (SD)
Physical function 53.1 (9.49) 71.5 (7.23) -21.41 to -15.26 0.0001
Emotional function 50.9 (13.96) 62.9 (11.75) -16.82 to -7.41 0.0001
Social function 62.5 (10.92) 72.8 (6.25) -13.50 to -7.01 0.0001
School function 36.2 (10.06) 56.0 (6.75) -22.95 to -16.71 0.0001
Total score 50.9 (7.55) 66.1 (4.35) -18.20 to -13.12 0.0001
Figure 1. Differences in quality of life between thalassemic children and their normal siblings
&, WR 3 HPRWLRQDO is a broad-ranging concept, affected in a complex way
IXQFWLRQ YV &, WR E\WKHSHUVRQ·VKHDOWKSV\FKRORJLFDOVWDWHSHUVRQDO
3 VRFLDO IXQFWLRQ YV &, beliefs, social relationships and their relationship to
WR3 DQGVFKRROIXQFWLRQ salient features of their environment.
YV&,WR3 7KH 7KHKHPDWRORJ\SURILOHVKRZHGRI
WRWDO VFRUHV ZHUH YV &, WR thalassemic patients to have beta thalassemia major
3 6FKRROIXQFWLRQZDVPRVWDIIHFWHG ZLWKPHDQDJHDWRQVHWRIDQHPLD\HDUVROGSUH
parameter (Figure 1). WUDQVIXVLRQKHPRJORELQOHYHOJG/DQGDJHDWILUVW
WUDQVIXVLRQ\HDUVROG0RUHWKDQKDOI
of the subjects were diagnosed with thalassemia at
Discussion WKHDJHRI!\HDUVDOWKRXJKWKH\KDGEHHQDQHPLF
EHIRUHWKHDJHRI\HDUV
We compared the quality of life of thalassemic Thalassemia is a chronic disease with serious
children to their normal siblings, as representative clinical symptoms. A study in Thailand found several
family members to assess the effects of the disease conditions that correlate to the severity of disease
and its treatment. The assessment of quality of life LQ WKDODVVHPLD SDWLHQWV DJH DW RQVHW RI DQHPLD
in children, especially in those with chronic diseases \HDUV ROG DJH DW ILUVW WUDQVIXVLRQ \HDUV ROG
such as thalassemia is important. The negative SUHWUDQVIXVLRQKHPRJORELQOHYHOJG/DQGEHWD
impact of the disease and its treatment can affect the thalassemia major.6
quality of life of patients and their family members, :H IRXQG WKDW RI DOO WKDODVVHPLF FKLOGUHQ·V
hence the need to assess both groups.The WHO SDUHQWVKDGERWKSDUHQWVDVFDUULHUV
GHILQHVTXDOLW\RIOLIHDVDQLQGLYLGXDO·VSHUFHSWLRQRI KDGRQHSDUHQWDVDFDUULHUDQGKDGXQNQRZQ
their position in life in the context of the culture and parental status. The above results are consistent with
value systems in which they live and in relation to thalassemic offspring often having carrier parents.
their goals, expectations, standards and concerns. It :H IRXQG RI WKH WKDODVVHPLF FKLOGUHQ WR EH
thalassemia major, a condition typically inherited from 3URJUHVVLYH LURQ RYHUORDG LV D FRQVHTXHQFH RI
two carrier parents. There was also a small number of ineffective erythropoiesis, increased gastrointestinal
other thalassemic children. absorption of iron and above all, multiple blood
Thalassemia major can often be prevented transfusions. (YHU\ PO RI UHG EORRG FHOOV
by avoiding marriage of two carrier parents or by WUDQVIXVHGFRQWDLQVDSSUR[LPDWHO\PJRILURQWKDW
performing prenatal diagnoses in high risk mothers.5,15 will circulate in the body, but the body cannot excrete
0DUULDJHRIWZRFDUULHUSDUHQWVUHVXOWVLQDFKDQFH more than 1 mg of iron per day.The accumulation
RI SURGXFLQJ WKDODVVHPLF RIIVSULQJ FKDQFH RI of iron results in progressive dysfunction of the heart,
producing a carrier who can pass on the disease if liver and endocrine glands.
KHVKHPDUULHVDQRWKHUFDUULHUDQGDFKDQFHRI Iron chelating agents are needed to control
normal offspring (not thalassemic or carrier).5,16 iron levels in patients who receive regular blood
$OPRVWDOORIWKHWKDODVVHPLFVXEMHFWV transfusions.'HIHUR[DPLQHKDVXQWLOQRZEHHQ
received monthly transfusions, with various blood considered the treatment of choice for patients with
volumes transfused depending on hemoglobin level chronic iron overload due to blood transfusion.
upon visiting the hospital. The most common amount The time to start the iron chelating agents is
RIEORRGWUDQVIXVHGZDVEDJVRIVXEMHFWVDQG GHWHUPLQHGE\WKHSDWLHQW·VVHUXPIHUULWLQDQGLURQ
the most common hemoglobin level upon hospital visit levels, as well as the total iron binding capacity after
ZDVJG/ regular transfusions. Chelating therapy is typically
In the management of thalassemia, regular red VWDUWHGLIWKHVHUXPIHUULWLQOHYHOH[FHHGVJ/
blood cell transfusions can reduce the complications of RUDIWHUUHFHLYLQJWUDQVIXVLRQV
anemia and ineffective erythropoiesis, permit normal We assessed the quality of life of thalassemic
growth and development throughout childhood, FKLOGUHQDQGWKHLUQRUPDOVLEOLQJVZLWKWKH3HGV4/
and extend survival in thalassemic children.1,15,17 YHUVLRQTXHVWLRQDLUH,QWKLVVWXG\ZHXVHGWKH
The decision to initiate regular transfusions is (QJOLVK,QGRQHVLDQYHUVLRQRI3HGV4/JHQHULFFRUH
generally based on the observation of a hemoglobin module in a sample of healthy children and children
concentration less than 6 g/dL.1,15 with thalassemia.
:HIRXQGPRVWVXEMHFWVKDGDQRUPDO ,QVWXGLHVRIFKLOGUHQ·VTXDOLW\RIOLIHWKHUHDUH
nutritional status, which is not in keeping with the generally two types of tools that can be used, generic
theory that children with thalassemia have growth measures and disease-specific measures. Each has its
problem. This was caused by the anthropometry data own advantages and disadvantages. Generic measure
showed abnormal condition (short stature) which in tools can be used in healthy or sick children with
turn resulting in normal nutritional status. various diseases. Hence, they can be used to compare
Children with thalassemia are known to have the quality of life of children with chronic illness to
abnormal growth. The etiology of these co-morbidities healthy children or children with other types of diseases.
is typically ascribed to the toxic effect of regular blood The disadvantage of these tools is that they cannot be
transfusions related to iron overload. Malnutrition used to assess specific symptoms of certain illnesses
is primarily caused by inadequate nutrient intake, as or possible side effects. On the other hand, specific
indicated by the capacity to gain weight appropriately measure tools cannot be used to compare sick children
when provided with nutritional support in the absence to healthy ones, but they are more sensitive and specific
of intestinal malabsorption. for certain symptoms or side effects of the disease.
0RVWVXEMHFWVLQRXUVWXG\KDGUHFHLYHG The choice of the tools depends on the subjects,
iron chelating therapy regularly after blood transfusions, specific conditions or the illness.14 The reliability and
with serum ferritin examinations every 3 months. We validity of the tool also determines the validity of the
IRXQGWKDWRIVXEMHFWVKDGVHUXPIHUULWLQ! assessment. For practical purposes, the ideal tool must
J/DQGKDGVHUXPIHUULWLQ!J/$IHZ be brief, but retain good reliability and validity, provide
subjects had not received chelating therapy because useful information, able to be filled by children of
WKHLUVHUXPIHUULWLQZDVOHVVWKDQJ/RUWKH\KDG various ages and their parents, and be available both
not been checked yet. in generic and specific measures.
5XQG ' 5DFKPLOHZLW] ( E thalassemia. N Eng J Med. $OL03XWUD67*DWRW'6DVWURDVPRUR6/HIWYHQWULFXODU
functions and mass of the adolescents and young adults
0DUHQJR5RZH$-7KHWKDODVVHPLDVDQGUHODWHGGLVRUGHUV ZLWKWKDODVVHPLDPDMRUDQHFKRFDUGLRJUDSK\VWXG\3DHGLDWU
3URF ,QGRQHV
7HOIHU3&RQVWDQWLQLGRX*$QGUHRX3&KULVWRX60RGHOO )LFD6$OEX$9ODGDUHDQX)%DUEX&%XQJKH]51LWX
%$QJDVWLQLRWLV04XDOLW\RIOLIHLQWKDODVVHPLD$QQ1< L, et al. Endocrine disorders in E thalassemia major: cross-
$FDG6FL VHFWLRQDOGDWD$FWD(QGRFULQRO
0D]]RQH/%DWWDJOLD/$QGUHR]]L)5RPHR0$0D]]RQH' $EHW] / %DODGL -) -RQHV 3 5RIDLO ' 7KH LPSDFW RI LURQ
Emotional impact in E thalassaemia major children following overload and its treatment on quality of life: results from a
cognitive behavioural family therapy and quality of life of OLWHUDWXUHUHYLHZ%LRPHG
FDUHJLYLQJPRWKHUV%LRPHG 9LQFHQW.$+LJJLQVRQ,-$VVHVVLQJTXDOLW\RIOLIHLQFKLOGUHQ
6KDOLJUDP ' *LULPDML 6& &KDWXWYHGL 6. 3V\FKRORJLFDO ,Q&DUU$-+LJJLQVRQ,-5RELQVRQ3*HGLWRUV%0-ERRNV
problems and quality of life in children with thalassemia. /RQGRQ%ULWLVK/LEUDU\&DWDORJXLQJS
,QGLDQ-3HGLDWU 6LWDUHVPL013HQLODLDQNXDOLWDVKLGXS\DQJEHUKXEXQJDQ
6KDUJKL$.DUEDNKVK01DEDHL%0H\VDPLH$)DUURNKL$ GHQJDQNHVHKDWDQKHDOWKUHODWHGTXDOLW\RIOLIH3UHVHQWHGDW
'HSUHVVLRQLQPRWKHUVRIFKLOGUHQZLWKWKDODVVHPLDRUEORRG 4th$QQXDO6FLHQWLILF0HHWLQJ,QGRQHVLDQ3HGLDWULFV6RFLHW\
PDOLJQDQFLHVDVWXG\IURP,UDQ%LRPHG )HEUXDU\0HGDQ,QGRQHVLD
7HVWD 0$ 6LPRQVRQ '& $VVHVVPHQW RI TXDOLW\ RI OLIH 9DUQL-:%XUZLQNOH70.DW](50HHVNH.'LFNLQVRQ3
RXWFRPHV1(QJO-0HG 7KH3HGV4/TM in pediatric cancer reliability and validity of
2OLYLHUL 1) :HDWKHUDOO '- 7KDODVVHPLDV ,Q $UFHFL 5- the pediatric quality of life inventoryTM generic core scales,
+DQQ,06PLWK23HGLWRUV3HGLDWULFKHPDWRORJ\$XVWUDOLD multidimensional fatigue scale, and cancer module. Am
%ODFNZHOO3XEOLVKLQJS &DQF6RF
16. Wahidiyat WI. Genetic problems at present and their 9DUQL -: 6HLG 0 .XUWLQ 36 3HGV4/ UHOLDELOLW\ DQG
FKDOOHQJHVLQWKHIXWXUHWKDODVVHPLDDVDPRGHO3DHGLDWU validity of the pediatric quality of life inventory TM version
,QGRQHV JHQHULFFRUHVFDOHVLQKHDOWK\DQGSDWLHQWSRSXODWLRQ
17. Honig GR. Thalassemia syndromes. In: Behrman RE, 0HG&DUH
Kliegman RM, Arvin AN, penyunting. Nelson textbook of %DDUV50$WKHUWRQ&,.RRSPDQ+0%XOOLQJHU03RZHU
pediatrics. 15th HG 3KLODGHOSKLD 6DXQGHUV (OVHYLHU 0',6$%.,'6JURXS7KH(XURSHDQ',6$%.,'6SURMHFW
S development of seven condition-specific modules to measure
)XQJ(%;X<.ZLDWNRZVNL-/9RJLDW]L0*1HXIHOG( health related quality of life in children and adolescents.
Olivieri N, et al. Relationship between chronic transfusion %LRPHG
therapy and body composition in subjects with thalassemia. (ZLQJ-(.LQJ076PLWK1)9DOLGDWLRQRIPRGLILHGIRUPV
-3HGLDWU RIWKH3HGV4/JHQHULFFRUHVFDOHVDQGFDQFHUPRGXOHVFDOHV
)XFKV*-7LHQERRQ3/LQSLVDUQ61LPVDNXO6/HHODSDW3 IRUDGROHVFHQWVDQG\RXQJDGXOWV$<$ZLWKFDQFHURUD
7RYDQDEXWUD6HWDO1XWULWLRQDOIDFWRUVDQGWKDODVVDHPLD EORRGGLVRUGHUV4XDO/LIH5HV
PDMRU$UFK'LV&KLOG 9DUQL -: 6KHUPDQ 6$ %XUZLQNOH 70 'LFNLQVRQ 3(
,NUDP 1 +DVVDQ . <RXQDV 0 $PDQDW 6 )HUULWLQ OHYHOV 'R[RQ37KH3HGV4/TM family impact module: preliminary
LQ SDWLHQWV RI EHWD WKDODVVDHPLD PDMRU ,QWHU - 3DWKRO UHOLDELOLW\DQGYDOLGLW\%LRPHG
8SWRQ 3 (LVHU & &KHXQJ , +XWFKLQJV +$ -HQQH\ 0
6DLG06DVWURDVPRUR6*DWRW'6XSUL\DWQR%$QDQWD< Maddocks A, et al. Measurement properties of the UK-
Comparison of pulmonary function of thalassemic and of (QJOLVKYHUVLRQRIWKHSHGLDWULFTXDOLW\RIOLIHLQYHQWRU\
KHDOWK\FKLOGUHQ3DHGLDWU,QGRQHV 3HGV4/JHQHULFFRUHVFDOH%LRPHG